| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
Division of GI/LiverPathology, and the Department of Surgery,
TheJohns Hopkins University School of Medicine, Baltimore, Maryland; andthe Departments of Surgery
andPathology,
Memorial Sloan-Kettering CancerCenter, New York, New York
Acinar cell carcinomas (ACCs) are rare malignant tumors of the exocrine pancreas. The specific molecular alterations that characterize ACCs have not yet been elucidated. ACCs are morphologically and genetically distinct from the more common pancreatic ductal adenocarcinomas. Instead, the morphological, immunohistochemical, and clinical features of ACCs overlap with those of another rare pancreatic neoplasm, pancreatoblastoma. We have recently demonstrated a high frequency of allelic loss on chromosome arm 11p and mutations in the APC/ß-catenin pathway in pancreatoblastomas, suggesting that similar alterations might also play a role in the pathogenesis of some ACCs. We analyzed a series of 21 ACCs for somatic alterations in the APC/ß-catenin pathway and for allelic loss on chromosome 11p. In addition, we evaluated the ACCs for alterations in p53 and Dpc4 expression using immunohistochemistry, and for microsatellite instability (MSI) using polymerase chain amplification of a panel of microsatellite markers. Allelic loss on chromosome 11p was the most common genetic alteration in ACCs, present in 50% (6 of 12 informative cases). Molecular alterations in the APC/ß-catenin pathway were detected in 23.5% (4 of 17) of the carcinomas, including one ACC with an activating mutation of the ß-catenin oncogene and three ACCs with truncating APC mutations. One ACC (1 of 13, 7.6%) showed allelic shifts in four of the five markers tested (MSI-high), two (15.4%) showed an allelic shift in only one of the five markers tested (MSI-low), and no shifts were detected in the remaining 10 cases. The MSI-high ACC showed medullary histological features. In contrast, no loss of Dpc4 protein expression or p53 accumulation was detected. These results indicate that ACCs are genetically distinct from pancreatic ductal adenocarcinomas, but some cases contain genetic alterations common to histologically similar pancreatoblastomas.
Related articles in Am J Pathol:
This article has been cited by other articles:
 |
|
 |
|
  R. B. Halberg, X. Chen, J. M. Amos-Landgraf, A. White, K. Rasmussen, L. Clipson, C. Pasch, R. Sullivan, H. C. Pitot, and W. F. Dove The Pleiotropic Phenotype of Apc Mutations in the Mouse: Allele Specificity and Effects of the Genetic Background Genetics, September 1, 2008; 180(1): 601 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Romero, M. Iglesias, C. P.H. Vary, and M. Quintanilla Functional blockade of Smad4 leads to a decrease in {beta}-catenin levels and signaling activity in human pancreatic carcinoma cells Carcinogenesis, May 1, 2008; 29(5): 1070 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Roldo, E. Missiaglia, J. P. Hagan, M. Falconi, P. Capelli, S. Bersani, G. A. Calin, S. Volinia, C.-G. Liu, A. Scarpa, et al. MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior J. Clin. Oncol., October 10, 2006; 24(29): 4677 - 4684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Chung, M. D. Travis, and R. M. Conran From the Archives of the AFIP: Pancreatic Tumors in Children: Radiologic-Pathologic Correlation. RadioGraphics, July 1, 2006; 26(4): 1211 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Bommer, C. Jager, E.-M. Durr, S. Baehs, S. T. Eichhorst, T. Brabletz, G. Hu, T. Frohlich, G. Arnold, D. C. Kress, et al. DRO1, a Gene Down-regulated by Oncogenes, Mediates Growth Inhibition in Colon and Pancreatic Cancer Cells J. Biol. Chem., March 4, 2005; 280(9): 7962 - 7975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-N. Qian, J. Knol, P. Igarashi, F. Lin, U. Zylstra, B. T. Teh, and B. O. Williams Cystic Renal Neoplasia Following Conditional Inactivation of Apc in Mouse Renal Tubular Epithelium J. Biol. Chem., February 4, 2005; 280(5): 3938 - 3945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Lewis, D. S. Klimstra, and H. E. Varmus The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer Genes & Dev., December 15, 2003; 17(24): 3127 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Holen, D. S. Klimstra, A. Hummer, M. Gonen, K. Conlon, M. Brennan, and L. B. Saltz Clinical Characteristics and Outcomes From an Institutional Series of Acinar Cell Carcinoma of the Pancreas and Related Tumors J. Clin. Oncol., December 15, 2002; 20(24): 4673 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Ashley and G. Y. Lauwers Case 37-2002 - A 69-Year-Old Man with Painful Cutaneous Nodules, Elevated Lipase Levels, and Abnormal Results on Abdominal Scanning N. Engl. J. Med., November 28, 2002; 347(22): 1783 - 1791. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Abraham, D. S. Klimstra, R. E. Wilentz, C. J. Yeo, K. Conlon, M. Brennan, J. L. Cameron, T.-T. Wu, and R. H. Hruban Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor {beta}-catenin Mutations Am. J. Pathol., April 1, 2002; 160(4): 1361 - 1369. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
